XPAC
Live / Registered — Registered (as of 04 Apr 2023)
What this means for you
Registered since 04 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97002544
- Registration number
- 7015434
- Mark type
- Stylized text
- Filed
- 30 Aug 2021
- Published for opposition
- 17 Jan 2023
- Registered
- 04 Apr 2023
- Attorney of record
- Nicole E. Reifman
Goods and services
- Class 001 — Chemicals: Chemicals used in the manufacture of pharmaceuticals; reagents, enzymes, and nucleotides for scientific or medical research; protein polymeric intermediates for use in the manufacture of pharmaceutical preparations; biomedical compounds, namely, peptides, peptidomimetics, and protein polymeric intermediates used in the manufacture of pharmaceutical preparations
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancerous, inflammatory, immunological, and viral diseases; pharmaceutical preparations for use in the field of oncology, immunology, and inflammation for the treatment of cancer, asthma, atopic dermatitis, peripheral inflammatory diseases, cardiovascular disease, autoimmune diseases; medical diagnostic reagents; reagents for use in testing proteins for medical and diagnostic purposes
Owner
- Amunix Pharmaceuticals, Inc., South San Francisco, CA, US
- Amunix Pharmaceuticals, Inc., South San Francisco, CA, US
- Amunix Pharmaceuticals, Inc., South San Francisco, CA, US
Prosecution history
- 04 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 17 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jan 2023 — PUBLISHED FOR OPPOSITION
- 28 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Dec 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Dec 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Dec 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Jun 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Jun 2022 — NON-FINAL ACTION E-MAILED
- 02 Jun 2022 — NON-FINAL ACTION WRITTEN
- 02 Jun 2022 — ASSIGNED TO EXAMINER
- 13 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Sept 2021 — NEW APPLICATION ENTERED